These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4818704)

  • 21. Effects of lidocaine and quinidine on post-repolarization refractoriness after the basic and premature action potentials: consideration of aim of antiarrhythmic drug therapy.
    Nakaya Y; Nii H; Nomura M; Fujino K; Mori H
    Am Heart J; 1989 Nov; 118(5 Pt 1):907-12. PubMed ID: 2479250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives.
    Ehring GR; Moyer JW; Hondeghem LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):479-92. PubMed ID: 2450194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural simularities and cardiac electrophysiological differences between lidocaine and procainamide.
    Ehring GR; Hondeghem LM
    Proc West Pharmacol Soc; 1980; 23():163-6. PubMed ID: 7403120
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of lidocaine, procaine, procainamide and quinidine on electrophysiological properties of cultured embryonic chick hearts.
    Riccioppo Neto FR; Sperelakis N
    Br J Pharmacol; 1985 Dec; 86(4):817-26. PubMed ID: 4075018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic drugs: electrophysiological and pharmacokinetic considerations.
    Sasyniuk BI; Ogilvie RI
    Annu Rev Pharmacol; 1975; 15():131-55. PubMed ID: 1096787
    [No Abstract]   [Full Text] [Related]  

  • 26. [The interaction of antiarrhythmic drugs with other drugs].
    Yamaguchi I
    Kokyu To Junkan; 1985 Aug; 33(8):956-69. PubMed ID: 2866571
    [No Abstract]   [Full Text] [Related]  

  • 27. The pharmacology of cardio-active agents.
    Hayes AH
    Cardiovasc Clin; 1972; 4(3):103-18. PubMed ID: 4130206
    [No Abstract]   [Full Text] [Related]  

  • 28. Electrophysiologic interactions between mexiletine-quinidine and mexiletine-ropitoin in guinea pig papillary muscle.
    Valenzuela C; Sanchez-Chapula J
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):783-9. PubMed ID: 2481194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of several new antiarrhythmic agents on atrial contractility.
    Covino BG; Shannon CM
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):185-92. PubMed ID: 5353470
    [No Abstract]   [Full Text] [Related]  

  • 30. Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction.
    Arnsdorf MF; Mehlman DJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):983-91. PubMed ID: 731444
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.
    Mason DT; DeMaria AN; Amsterdam EA; Zelis R; Massumi RA
    Drugs; 1973; 5(4):261-91. PubMed ID: 4146767
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative mechanisms of antiarrhythmic agents.
    Pamintuan JC; Dreifus LS; Watanabe Y
    Am J Cardiol; 1970 Nov; 26(5):512-9. PubMed ID: 5478839
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative studies on the pharmacological actions of anti-arrhythmics in isolated guinea-pig atria.
    Nagata M; Sugimoto J; Morita M
    Jpn Circ J; 1973 Jun; 37(6):641-6. PubMed ID: 4800402
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiarrhythmic structure activity relationships in a series of lidocaine procainamide derivatives.
    Ehring GR; Hondeghem LM
    Proc West Pharmacol Soc; 1981; 24():221-4. PubMed ID: 7255453
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of quinidine, procainamide, lidocaine and phenytoin on inotropic responses to acetylcholine and norepinephrine.
    Chiba S
    Jpn J Pharmacol; 1976 Apr; 26(2):267-8. PubMed ID: 940233
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiarrhythmic agents and their use in therapy.
    Dreifus LS; Morganroth J
    Pharmacol Ther; 1980; 9(1):75-106. PubMed ID: 6994141
    [No Abstract]   [Full Text] [Related]  

  • 37. Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs.
    Hasannejad H; Takeda M; Narikawa S; Huang XL; Enomoto A; Taki K; Niwa T; Jung SH; Onozato ML; Tojo A; Endou H
    Eur J Pharmacol; 2004 Sep; 499(1-2):45-51. PubMed ID: 15363950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of some antiarrhythmic agents on electrically induced convulsive seizures in rats.
    Phansalkar AG; Kulkarni SD; Balwani JH
    Indian J Physiol Pharmacol; 1970 Jul; 14(3):181-3. PubMed ID: 5527060
    [No Abstract]   [Full Text] [Related]  

  • 39. [Action of anti-arrhythmia agents on intracardiac conduction].
    Kulbertus H; Collignon P
    Acta Cardiol; 1974; Suppl 18():241-50. PubMed ID: 4547514
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical pharmacology of anti-arrhythmia agents].
    Rahn KH
    Verh Dtsch Ges Inn Med; 1975; 81():111-9. PubMed ID: 1229410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.